Form 8-K - Current report:
SEC Accession No. 0000950170-24-125337
Filing Date
2024-11-12
Accepted
2024-11-12 16:05:15
Documents
12
Period of Report
2024-11-12
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K eras-20241112.htm   iXBRL 8-K 38040
2 EX-99.1 eras-ex99_1.htm EX-99.1 142563
  Complete submission text file 0000950170-24-125337.txt   308013

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT eras-20241112.xsd EX-101.SCH 25793
14 EXTRACTED XBRL INSTANCE DOCUMENT eras-20241112_htm.xml XML 4879
Mailing Address 10835 ROAD TO THE CURE, SUITE 140 SAN DIEGO CA 92121
Business Address 10835 ROAD TO THE CURE, SUITE 140 SAN DIEGO CA 92121 (858) 465-6511
Erasca, Inc. (Filer) CIK: 0001761918 (see all company filings)

EIN.: 831217027 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40602 | Film No.: 241447935
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)